Akretive Holdings, LLC filed a Schedule 13D with the SEC on November 4, 2026, disclosing that it acquired 2,229,805 shares of cbdMD, Inc. common stock on October 30, 2026, representing approximately 15.9% of the company's outstanding shares.

Key Highlights

  • Shares acquired: Akretive Holdings, LLC acquired 2,229,805 shares of cbdMD, Inc. common stock on October 30, 2026.
  • Ownership stake: The 2,229,805 shares represent approximately 15.9% of the 14,048,386 outstanding shares of cbdMD common stock as of October 30, 2026.
  • Transaction basis: Shares were acquired pursuant to an Asset Purchase Agreement dated September 1, 2026, involving cbdMD, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., and Philip J. Von Kahle as assignee for the benefit of creditors.
  • Director nomination right: The Asset Purchase Agreement provides Akretive Holdings with the right to nominate a director for consideration by cbdMD's Nominating and Corporate Governance Committee.
  • Additional instrument: The Reporting Person also acquired a Senior Secured Promissory Note as part of the transaction.
  • Control of shares: Patrick Ogle, Managing Member of Akretive LLC (itself the Managing Member of Akretive Holdings, LLC), holds sole voting and dispositive power over all 2,229,805 shares.

Akretive Holdings' Entry Into cbdMD via Asset Purchase Agreement

According to the Schedule 13D filing, Akretive Holdings, LLC, a New York limited liability company, became a significant shareholder of cbdMD, Inc. through an Asset Purchase Agreement dated September 1, 2026. The transaction closed on October 30, 2026, at which point Akretive Holdings received 2,229,805 shares of cbdMD common stock, $0.001 par value. The filing identifies the source of funds as "OO," indicating other sources outside of personal funds or standard borrowings.

The filing discloses that the Asset Purchase Agreement was entered into among cbdMD, Inc., To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., and Philip J. Von Kahle in his capacity as the duly appointed assignee for the benefit of creditors, in addition to Akretive Holdings. Under the terms described in the filing, Akretive Holdings obtained the right to nominate a director for the Nominating and Corporate Governance Committee of cbdMD to consider. The Reporting Person also received a Senior Secured Promissory Note as part of the same transaction.

As reported in the filing, the 2,229,805 shares represent approximately 15.9% of cbdMD's 14,048,386 outstanding shares of common stock as of October 30, 2026. Patrick Ogle, identified as the Managing Member of Akretive LLC and therefore the ultimate controlling person of Akretive Holdings, LLC, holds sole voting power and sole dispositive power over all shares beneficially owned by the Reporting Person. The filing states that neither Akretive Holdings nor Patrick Ogle has been subject to relevant criminal or civil securities-law proceedings in the past five years.

What Was Disclosed

Akretive Holdings, LLC filed a Schedule 13D reporting the acquisition of 2,229,805 cbdMD common shares on October 30, 2026, amounting to approximately 15.9% of outstanding shares, through an Asset Purchase Agreement that also grants a director nomination right and includes a Senior Secured Promissory Note.